Coffee and registration
Welcome and introduction
Päivi Östling, SciLifeLab
Functional precision cancer medicine—moving beyond pure genomics
Anthony Letai, Dana-Farber Cancer Institute, Boston, USA
Defining drug action at single cell resolution
Gregory Vladimer, Allcyte, Vienna Austria
Functional systems precision cancer medicine- lessons learned from AML
Olli Kallioniemi, SciLifeLab, Sweden
Proteogenomics in cancer
Henrik Johansson, Karolinska Institutet
The CETSA in determining drug-target engagement
Brinton Seashore-Ludlow, Karolinska Institutet
Conclusions & Discussion
Thomas Helleday, SciLifeLab
This event is now fully booked.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.